Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-88.84	17.60	157.66
Graham Fair Price	22.58	19670.31	16047.10
PEG	-61.57	0.12	-0.32
Price/Book	-4.15	0.92	0.96
Price/Cash Flow	-8.80	40.37	44.27
Prices/Earnings	-37.29	6.29	10.02
Price/Sales	-30.12	2.54	3.63
Price/FCF	-8.80	40.37	44.27
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	84.62	0.14	0.07
Operating Margin	1383.99	0.10	< 0.005
ROA	47.29	0.03	0.02
ROE	0.02	0.04	52.85
ROIC	< 0.005	0.03	924.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.06	66.76
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.05	21.18	1914.70
EPS QOQ	-0.32	0.52	63.17
FCF QOQ	0.92	0.04	-95.44
Revenue QOQ	-0.07	0.36	440.36
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.56	17.42	-31.83
Days Sales Outstanding (DSO)	63.25	50.00	-20.95
Inventory Turnover	3.52	5.17	46.69
Debt/Capitalization	0.02	0.02	0.07
Quick Ratio	2.11	1.90	-9.74
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21903.55	21716.63	-0.85
Cash	7607.61	8072.06	6.11
Capex	-411.19	-285.47	30.57
Free Cash Flow	473.28	493.21	4.21
Revenue	5764.82	7839.64	35.99
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.54	2.25	-11.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.20	-1.19	87.11
Naive Interpretation	Member

06 - Financial Health · Bad

Rating